Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)
CNY 15.64
(0.77%)
CNY 15.64
(0.77%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.78 Billion CNY | 9.25% |
| 2022 | 5.29 Billion CNY | 1.93% |
| 2021 | 5.19 Billion CNY | 3.36% |
| 2020 | 5.02 Billion CNY | -4.75% |
| 2019 | 5.27 Billion CNY | 34.6% |
| 2018 | 3.91 Billion CNY | 6.39% |
| 2017 | 3.68 Billion CNY | 5.63% |
| 2016 | 3.48 Billion CNY | 2.24% |
| 2015 | 3.4 Billion CNY | 4.98% |
| 2014 | 3.24 Billion CNY | 0.8% |
| 2013 | 3.22 Billion CNY | 9.79% |
| 2012 | 2.93 Billion CNY | 2.53% |
| 2011 | 2.86 Billion CNY | 4.95% |
| 2010 | 2.72 Billion CNY | 209.16% |
| 2009 | 882.13 Million CNY | 18.35% |
| 2008 | 745.35 Million CNY | -14.73% |
| 2007 | 874.1 Million CNY | 1.23% |
| 2006 | 863.48 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 6.01 Billion CNY | -0.56% |
| 2024 Q1 | 6.07 Billion CNY | 5.1% |
| 2024 Q2 | 6.05 Billion CNY | -0.4% |
| 2023 Q3 | 5.56 Billion CNY | 5.1% |
| 2023 Q1 | 5.35 Billion CNY | 1.3% |
| 2023 FY | 5.78 Billion CNY | 9.25% |
| 2023 Q4 | 5.78 Billion CNY | 3.94% |
| 2023 Q2 | 5.29 Billion CNY | -1.27% |
| 2022 Q3 | 5.41 Billion CNY | 1.08% |
| 2022 FY | 5.29 Billion CNY | 1.93% |
| 2022 Q4 | 5.29 Billion CNY | -2.24% |
| 2022 Q1 | 5.27 Billion CNY | 1.68% |
| 2022 Q2 | 5.35 Billion CNY | 1.45% |
| 2021 Q1 | 5.06 Billion CNY | 0.77% |
| 2021 Q3 | 5.08 Billion CNY | -0.22% |
| 2021 FY | 5.19 Billion CNY | 3.36% |
| 2021 Q4 | 5.19 Billion CNY | 2.17% |
| 2021 Q2 | 5.09 Billion CNY | 0.61% |
| 2020 Q1 | 5.28 Billion CNY | 0.21% |
| 2020 Q2 | 5.23 Billion CNY | -0.86% |
| 2020 FY | 5.02 Billion CNY | -4.75% |
| 2020 Q3 | 5.19 Billion CNY | -0.77% |
| 2020 Q4 | 5.02 Billion CNY | -3.39% |
| 2019 Q2 | 5.63 Billion CNY | 1.32% |
| 2019 Q3 | 5.62 Billion CNY | -0.35% |
| 2019 FY | 5.27 Billion CNY | 34.6% |
| 2019 Q1 | 5.56 Billion CNY | 42.1% |
| 2019 Q4 | 5.27 Billion CNY | -6.18% |
| 2018 Q4 | 3.91 Billion CNY | 1.26% |
| 2018 FY | 3.91 Billion CNY | 6.39% |
| 2018 Q3 | 3.86 Billion CNY | 0.95% |
| 2018 Q2 | 3.83 Billion CNY | 0.42% |
| 2018 Q1 | 3.81 Billion CNY | 3.63% |
| 2017 FY | 3.68 Billion CNY | 5.63% |
| 2017 Q4 | 3.68 Billion CNY | 2.96% |
| 2017 Q3 | 3.57 Billion CNY | 2.21% |
| 2017 Q2 | 3.49 Billion CNY | -1.19% |
| 2017 Q1 | 3.54 Billion CNY | 1.59% |
| 2016 Q1 | 3.42 Billion CNY | 0.34% |
| 2016 Q2 | 3.4 Billion CNY | -0.5% |
| 2016 Q4 | 3.48 Billion CNY | 2.88% |
| 2016 Q3 | 3.38 Billion CNY | -0.46% |
| 2016 FY | 3.48 Billion CNY | 2.24% |
| 2015 Q4 | 3.4 Billion CNY | 3.21% |
| 2015 FY | 3.4 Billion CNY | 4.98% |
| 2015 Q3 | 3.3 Billion CNY | -0.69% |
| 2015 Q2 | 3.32 Billion CNY | 2.28% |
| 2015 Q1 | 3.25 Billion CNY | 0.13% |
| 2014 Q1 | 3.26 Billion CNY | 1.3% |
| 2014 FY | 3.24 Billion CNY | 0.8% |
| 2014 Q4 | 3.24 Billion CNY | 3.28% |
| 2014 Q3 | 3.14 Billion CNY | -1.17% |
| 2014 Q2 | 3.18 Billion CNY | -2.52% |
| 2013 Q1 | 3.03 Billion CNY | 3.48% |
| 2013 FY | 3.22 Billion CNY | 9.79% |
| 2013 Q2 | 3.14 Billion CNY | 3.43% |
| 2013 Q3 | 3.14 Billion CNY | 0.26% |
| 2013 Q4 | 3.22 Billion CNY | 2.32% |
| 2012 Q4 | 2.93 Billion CNY | 1.42% |
| 2012 Q1 | 2.98 Billion CNY | 4.12% |
| 2012 FY | 2.93 Billion CNY | 2.53% |
| 2012 Q2 | 2.82 Billion CNY | -5.17% |
| 2012 Q3 | 2.89 Billion CNY | 2.39% |
| 2011 Q4 | 2.86 Billion CNY | 0.65% |
| 2011 Q1 | 2.9 Billion CNY | 6.49% |
| 2011 FY | 2.86 Billion CNY | 4.95% |
| 2011 Q3 | 2.84 Billion CNY | 1.75% |
| 2011 Q2 | 2.79 Billion CNY | -3.76% |
| 2010 Q2 | 2.71 Billion CNY | 234.02% |
| 2010 Q4 | 2.72 Billion CNY | -0.78% |
| 2010 FY | 2.72 Billion CNY | 209.16% |
| 2010 Q1 | 813.95 Million CNY | -7.73% |
| 2010 Q3 | 2.74 Billion CNY | 1.1% |
| 2009 Q4 | 882.13 Million CNY | 0.0% |
| 2009 FY | 882.13 Million CNY | 18.35% |
| 2009 Q2 | 920.45 Million CNY | 0.0% |
| 2008 FY | 745.35 Million CNY | -14.73% |
| 2007 FY | 874.1 Million CNY | 1.23% |
| 2006 FY | 863.48 Million CNY | 0.0% |